Chin-Chuan Chen Selected Research

hydroxygenkwanin

9/2021	Hydroxygenkwanin Increases the Sensitivity of Liver Cancer Cells to Chemotherapy by Inhibiting DNA Damage Response in Mouse Xenograft Models.
1/2020	Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells.
12/2019	Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chin-Chuan Chen Research Topics

Disease

20	Neoplasms (Cancer) 01/2023 - 01/2015
8	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 10/2017
4	Liver Neoplasms (Liver Cancer) 09/2021 - 12/2019
3	Hyperplasia 02/2024 - 01/2016
3	Lung Neoplasms (Lung Cancer) 01/2023 - 12/2017
3	Inflammation (Inflammations) 03/2020 - 11/2017
2	Squamous Cell Carcinoma of Head and Neck 09/2021 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 11/2019
2	Obesity 01/2021 - 01/2019
2	Insulin Resistance 01/2021 - 01/2019
1	COVID-19 04/2024
1	Virus Diseases (Viral Diseases) 04/2024
1	Necrosis 02/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023
1	Breast Neoplasms (Breast Cancer) 09/2021
1	Body Weight (Weight, Body) 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Atherosclerotic Plaque (Atheroma) 03/2020
1	Atherosclerosis 03/2020
1	Fibrosis (Cirrhosis) 01/2019
1	Skin Diseases (Skin Disease) 01/2015
1	Dermatitis 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Genomic Instability 02/2014
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2002
1	Carcinogenesis 02/2002

Drug/Important Bio-Agent (IBA)

5	corylinIBA 11/2023 - 01/2018
4	Long Noncoding RNAIBA 01/2019 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2019
3	hydroxygenkwaninIBA 09/2021 - 12/2019
3	FlavonoidsIBA 01/2021 - 11/2017
3	RNA (Ribonucleic Acid)IBA 01/2019 - 08/2017
3	MelatoninIBA 09/2018 - 10/2017
3	Etoposide (VP 16)FDA LinkGeneric 09/2018 - 12/2017
2	QuercetinIBA 04/2024 - 01/2021
2	CytokinesIBA 02/2024 - 11/2017
2	Becaplermin (PDGF-BB)FDA Link 02/2024 - 01/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 11/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2020 - 11/2019
2	LipidsIBA 03/2020 - 01/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2020 - 01/2020
2	MicroRNAs (MicroRNA)IBA 12/2019 - 09/2018
2	growth arrest specific transcript 5IBA 01/2019 - 01/2018
1	ApelinIBA 02/2024
1	Platelet-Derived Growth FactorIBA 02/2024
1	isoxanthohumolIBA 02/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Particulate MatterIBA 01/2023
1	Phosphotransferases (Kinase)IBA 05/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2021
1	palbociclibIBA 09/2021
1	CurcuminIBA 04/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2021
1	Therapeutic UsesIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	brigatinibIBA 01/2021
1	ApolipoproteinsIBA 03/2020
1	Apolipoproteins E (ApoE)IBA 03/2020
1	magnololIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 01/2020
1	Histone Deacetylase InhibitorsIBA 01/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 12/2019
1	sulforaphaneIBA 11/2019
1	diallyl disulfide (diallyl disulphide)IBA 10/2019
1	hnRNP A2IBA 03/2019
1	Heterogeneous Nuclear Ribonucleoprotein A1IBA 03/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2019
1	pigment epithelium-derived factorIBA 01/2019
1	PalmitatesIBA 01/2019
1	Sirtuin 1IBA 12/2017
1	Cisplatin (Platino)FDA LinkGeneric 12/2017
1	artocarpin lectinIBA 11/2017
1	viscolinIBA 01/2016
1	rhodamine BIBA 01/2015
1	Imiquimod (Aldara)FDA LinkGeneric 01/2015
1	Nucleosomes (Nucleosome)IBA 02/2014
1	Messenger RNA (mRNA)IBA 02/2002
1	Complementary DNA (cDNA)IBA 02/2002
1	Adenosine Triphosphatases (ATPase)IBA 02/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 09/2021 - 12/2017
4	Therapeutics 04/2024 - 01/2015
4	Radiotherapy 09/2021 - 01/2015
1	Adjuvant Chemotherapy 09/2021